Experimental Treatment of Measles Encephalitis With Inosine Pranobex and Remdesivir in a Child With Lymphocytic...

Area of Science:

• Pediatric Oncology
• Infectious Diseases
• Neurology

Background:

• Measles encephalitis is a severe complication in children with hematolymphoid malignancies undergoing chemotherapy.
• Current treatment for measles encephalitis is largely supportive, with no effective strategies to mitigate significant morbidity.

Purpose of the Study:

• To report a novel antiviral combination therapy for measles encephalitis in a pediatric patient with B-acute lymphoblastic leukemia.
• To evaluate the efficacy of this novel treatment in preventing severe sequelae and promoting recovery.

Main Methods:

• A case study of a child with B-acute lymphoblastic leukemia and measles encephalitis.
• Administration of a novel combination of antiviral agents.

Main Results:

• The novel antiviral combination therapy successfully abrogated the morbid sequelae of measles encephalitis.
• The patient achieved complete recovery from measles encephalitis.

Conclusions:

• A novel antiviral combination therapy shows promise in treating measles encephalitis in immunocompromised children.
• This approach may offer an effective strategy to mitigate morbidity and mortality associated with measles encephalitis.